RETRACTED ARTICLE: N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner

The Publisher of the journal <i>Bioengineered</i>, have retracted the following article: Miao YQ, Chen W, Zhou J, Shen Q, Sun Y, Li T, Wang SC. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner. Bioengineered. 2022 Jan;13(1):1858-1871. doi: 10.1080/21655979.2021.2018386. Since publication, significant concerns have been raised about the compliance with ethical policies for human research and the integrity of the data reported in the article. When approached for an explanation, the authors provided some original data but were not able to provide all the necessary supporting information. As verifying the validity of published work is core to the scholarly record’s integrity, we are retracting the article. All authors listed in this publication have been informed. We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted.’

《Bioengineered》期刊的出版方已撤回以下文章：Miao YQ、Chen W、Zhou J、Shen Q、Sun Y、Li T、Wang SC. N(6)-腺苷甲基转移酶14（N(6)-adenosine-methyltransferase-14）以m6A依赖方式抑制精氨酸琥珀酸合成酶1表达，促进胶质瘤发生。Bioengineered. 2022年1月;13(1):1858-1871. DOI: 10.1080/21655979.2021.2018386。该文章发表后，学界对其人体研究的伦理合规性及报道数据的完整性提出了严重质疑。当编辑部向作者索要解释时，作者仅提供了部分原始数据，无法提供全部必要的佐证材料。鉴于验证已发表研究的有效性是维护学术记录完整性的核心要义，本刊决定撤回该文章。本刊已告知该文章所有署名作者。本次撤稿决定的制定依据本刊编辑规范及国际出版伦理委员会（COPE）指南。被撤回的文章将继续在线保留以维持学术记录的完整性，但每一页都将被添加数字水印，标注为"Retracted"。